Vulnerability Description
The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable `/proxy` endpoint entirely via, for example, nginx.
CVSS Score
HIGH
Related Weaknesses (CWE)
References
- https://github.com/cBioPortal/cbioportal/commit/ea8642fdbda2d61d2ab34b9da7a15946
- https://github.com/cBioPortal/cbioportal/pull/10884
- https://github.com/cBioPortal/cbioportal/releases/tag/v6.0.12
- https://github.com/cBioPortal/cbioportal/security/advisories/GHSA-9h44-r3c3-q7rm
- https://www.wizlynxgroup.com/security-research-advisories/vuln/WLX-2024-004
- https://github.com/cBioPortal/cbioportal/commit/ea8642fdbda2d61d2ab34b9da7a15946
- https://github.com/cBioPortal/cbioportal/pull/10884
- https://github.com/cBioPortal/cbioportal/releases/tag/v6.0.12
- https://github.com/cBioPortal/cbioportal/security/advisories/GHSA-9h44-r3c3-q7rm
- https://www.wizlynxgroup.com/security-research-advisories/vuln/WLX-2024-004
FAQ
What is CVE-2024-41668?
CVE-2024-41668 is a vulnerability with a CVSS score of 8.3 (HIGH). The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioP...
How severe is CVE-2024-41668?
CVE-2024-41668 has been rated HIGH with a CVSS base score of 8.3/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2024-41668?
Check the references section above for vendor advisories and patch information. Review vendor security bulletins for remediation guidance.